Intelligent Neurological Function Evaluation System

Publication ID: 24-11857349_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Neurological Function Evaluation System,” Published Technical Disclosure No. 24-11857349_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857349_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,349.

Summary of the Inventive Concept

An integrated system for evaluating neurological function, combining a computing device, a specialized apparatus, and advanced technologies like AI, IoT, blockchain, and novel materials to provide personalized, accurate, and secure assessments.

Background and Problem Solved

The original patent provided a system for evaluating neurological function, but it had limitations in terms of data security, accuracy, and user experience. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a more comprehensive and effective system.

Detailed Description of the Inventive Concept

The system comprises a computing device with a touch screen, an apparatus configured to attach to the computing device, and advanced technologies such as AI, IoT, blockchain, and novel materials. The AI module utilizes machine learning algorithms to analyze user interactions with the touch screen and provide personalized cognitive and/or neuromotor assessments. The blockchain-based data storage system securely stores and manages user data and test results. The IoT-enabled sensor system tracks user movements and provides real-time feedback during the test. The novel material-based haptic feedback system provides tactile feedback to users during the test. The system also integrates a machine learning-based predictive analytics system that identifies patterns in user data and provides personalized recommendations for improving cognitive and/or neuromotor function.

Novelty and Inventive Step

The new claims introduce novel combinations of technologies that enhance the accuracy, security, and user experience of the original system. The integration of AI, IoT, blockchain, and novel materials provides a unique and non-obvious solution to the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the system could include varying the type of computing device, using different AI algorithms, or incorporating additional sensors or feedback mechanisms. The system could also be adapted for use in different environments, such as clinical settings or remote testing.

Potential Commercial Applications and Market

The Intelligent Neurological Function Evaluation System has significant commercial potential in the healthcare and medical industries, particularly in the areas of neurological disease diagnosis and treatment. The system's ability to provide accurate, personalized, and secure assessments makes it an attractive solution for clinicians, researchers, and patients.

CPC Classifications

SectionClassGroup
A A61 A61B5/7271
A A61 A61B3/032
A A61 A61B5/11
A A61 A61B5/112
A A61 A61B5/1124
A A61 A61B5/1125
A A61 A61B5/16
A A61 A61B5/165
A A61 A61B5/225
A A61 A61B5/4023
A A61 A61B5/4076
A A61 A61B5/4082
A A61 A61B5/4088
A A61 A61B5/162
A A61 A61B2560/04
A A61 A61B2562/0219
G G06 G06F2203/04809

Original Patent Information

Patent NumberUS 11,857,349
TitleApparatus and related method to facilitate test via a computing device
Assignee(s)THE CLEVELAND CLINIC FOUNDATION, BIOGEN MA INC.